Challenges in ADC Production - Consolidating Operations Under One Roof

[Article Title]

Antibody Drug Conjugates (ADC) production comes with inherent challenges owing mainly to the toxicity of the highly potent payload or warhead used in the production process. In this whitepaper, Eurofins CDMO Alphora demonstrates developed and validated processes to mitigate risks associated with cross-contamination.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.